Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.8
5.6
Journals
IJMS
Special Issues
Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules
ijms-logo
Submit to IJMS Review for IJMS Propose a Special Issue

Journal Menu

► Journal Menu

Journal Browser

► Journal Browser
share announcement

Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: closed (30 August 2020) | Viewed by 67269

Special Issue Editor

Dr. Anne Vejux

E-Mail Website
Guest Editor
Team “Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism”, Université de Bourgogne, 21000 Dijon, France
Interests: oxysterols; very-long-chain fatty acids; lipid metabolism; diet, peroxisomes; biotherapies; inflammation; cancer; cell cycle and apoptosis; autophagy; biological membranes; oxidative damage; biomarkers; neurodegenerative diseases
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

 

Neurodegenerative diseases represent a major societal challenge. These are not diseases with a short life-threatening prognosis, but they are very debilitating, make heavy demands on carers and require the establishment of appropriate centres for patient care. It is therefore important to know even more about the mechanisms involved in the physiopathogenesis of these diseases.

 

Neurodegenerative diseases include demyelinating neurodegenerative diseases: multiple sclerosis and peroxysomal and nondemyelinating leukodystrophies: Alzheimer’s disease, Parkinson’s disease, Niemann–Pick disease, Huntington’s disease and amyotrophic lateral sclerosis or Charcot disease. One of the mechanisms involved in these pathologies is cell death, whether it be a cause or a consequence of the disease. It is therefore important to better understand the involvement of cell death, the cellular and molecular mechanisms leading to it and to identify the natural or unnatural molecules that can thwart this cell death. Apoptosis, autophagy, necroptosis or other forms of cell death can be interesting therapeutic targets to combat the development of these neurodegenerative diseases.

Dr. Anne Vejux
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • apoptosis
  • autophagy
  • necrosis
  • reticulum stress
  • natural molecules
  • oxidative stress
  • therapeutic
  • signalling pathways

Related Special Issue

Published Papers (14 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Editorial

Jump to: Research, Review

3 pages, 190 KiB  
Editorial
Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules
by Anne Vejux
Int. J. Mol. Sci. 2023, 24(14), 11465; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms241411465 - 14 Jul 2023
Viewed by 613
Abstract
A neurodegenerative disease is a pathological condition affecting neurons, condemning them to death [...] Full article
(This article belongs to the Special Issue Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules)

Research

Jump to: Editorial, Review

14 pages, 1782 KiB  
Article
β-Naphthoflavone and Ethanol Reverse Mitochondrial Dysfunction in A Parkinsonian Model of Neurodegeneration
by Jesus Fernandez-Abascal, Elda Chiaino, Maria Frosini, Gavin P. Davey and Massimo Valoti
Int. J. Mol. Sci. 2020, 21(11), 3955; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21113955 - 31 May 2020
Cited by 7 | Viewed by 2462
Abstract
The 1-methyl-4-phenylpyridinium (MPP+) is a parkinsonian-inducing toxin that promotes neurodegeneration of dopaminergic cells by directly targeting complex I of mitochondria. Recently, it was reported that some Cytochrome P450 (CYP) isoforms, such as CYP 2D6 or 2E1, may be involved in the [...] Read more.
The 1-methyl-4-phenylpyridinium (MPP+) is a parkinsonian-inducing toxin that promotes neurodegeneration of dopaminergic cells by directly targeting complex I of mitochondria. Recently, it was reported that some Cytochrome P450 (CYP) isoforms, such as CYP 2D6 or 2E1, may be involved in the development of this neurodegenerative disease. In order to study a possible role for CYP induction in neurorepair, we designed an in vitro model where undifferentiated neuroblastoma SH-SY5Y cells were treated with the CYP inducers β-naphthoflavone (βNF) and ethanol (EtOH) before and during exposure to the parkinsonian neurotoxin, MPP+. The toxic effect of MPP+ in cell viability was rescued with both βNF and EtOH treatments. We also report that this was due to a decrease in reactive oxygen species (ROS) production, restoration of mitochondrial fusion kinetics, and mitochondrial membrane potential. These treatments also protected complex I activity against the inhibitory effects caused by MPP+, suggesting a possible neuroprotective role for CYP inducers. These results bring new insights into the possible role of CYP isoenzymes in xenobiotic clearance and central nervous system homeostasis. Full article
(This article belongs to the Special Issue Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules)
►▼ Show Figures

Figure 1

20 pages, 3014 KiB  
Article
An α5 GABAA Receptor Inverse Agonist, α5IA, Attenuates Amyloid Beta-Induced Neuronal Death in Mouse Hippocampal Cultures
by Chitra Vinnakota, Karan Govindpani, Warren Perry Tate, Katie Peppercorn, Praju Vikas Anekal, Henry John Waldvogel, Richard Lewis Maxwell Faull and Andrea Kwakowsky
Int. J. Mol. Sci. 2020, 21(9), 3284; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21093284 - 06 May 2020
Cited by 9 | Viewed by 3465
Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder for which no cognition-restoring therapies exist. Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the brain. Increasing evidence suggests a remodeling of the GABAergic system in AD, which might represent an important therapeutic target. [...] Read more.
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder for which no cognition-restoring therapies exist. Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the brain. Increasing evidence suggests a remodeling of the GABAergic system in AD, which might represent an important therapeutic target. An inverse agonist of α5 subunit-containing GABAA receptors (α5GABAARs), 3-(5-Methylisoxazol-3-yl)-6-[(1-methyl-1,2,3-triazol-4-yl)methyloxy]-1,2,4-triazolo[3–a]phthalazine (α5IA) has cognition-enhancing properties. This study aimed to characterize the effects of α5IA on amyloid beta (Aβ1–42)-induced molecular and cellular changes. Mouse primary hippocampal cultures were exposed to either Aβ1-42 alone, or α5IA alone, α5IA with Aβ1–42 or vehicle alone, and changes in cell viability and mRNA expression of several GABAergic signaling components were assessed. Treatment with 100 nM of α5IA reduced Aβ1–42-induced cell loss by 23.8% (p < 0.0001) after 6 h and by 17.3% after 5 days of treatment (p < 0.0001). Furthermore, we observed an Aβ1-42-induced increase in ambient GABA levels, as well as upregulated mRNA expression of the GABAAR α2,α5,β2/3 subunits and the GABABR R1 and R2 subunits. Such changes in GABARs expression could potentially disrupt inhibitory neurotransmission and normal network activity. Treatment with α5IA restored Aβ1-42-induced changes in the expression of α5GABAARs. In summary, this compound might hold neuroprotective potential and represent a new therapeutic avenue for AD. Full article
(This article belongs to the Special Issue Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules)
►▼ Show Figures

Figure 1

19 pages, 2831 KiB  
Article
Transcriptomic and Network Analysis Identifies Shared and Unique Pathways across Dementia Spectrum Disorders
by Jose A. Santiago, Virginie Bottero and Judith A. Potashkin
Int. J. Mol. Sci. 2020, 21(6), 2050; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21062050 - 17 Mar 2020
Cited by 16 | Viewed by 3748
Abstract
Background: Dementia is a growing public health concern with an estimated prevalence of 50 million people worldwide. Alzheimer’s disease (AD) and vascular and frontotemporal dementias (VaD, FTD), share many clinical, genetical, and pathological features making the diagnosis difficult. Methods: In this study, we [...] Read more.
Background: Dementia is a growing public health concern with an estimated prevalence of 50 million people worldwide. Alzheimer’s disease (AD) and vascular and frontotemporal dementias (VaD, FTD), share many clinical, genetical, and pathological features making the diagnosis difficult. Methods: In this study, we compared the transcriptome from the frontal cortex of patients with AD, VaD, and FTD to identify dysregulated pathways. Results: Upregulated genes in AD were enriched in adherens and tight junctions, mitogen-activated protein kinase, and phosphatidylinositol 3-kinase and protein kinase B/Akt signaling pathways, whereas downregulated genes associated with calcium signaling. Upregulated genes in VaD were centered on infectious diseases and nuclear factor kappa beta signaling, whereas downregulated genes are involved in biosynthesis of amino acids and the pentose phosphate pathway. Upregulated genes in FTD were associated with ECM receptor interactions and the lysosome, whereas downregulated genes were involved in glutamatergic synapse and MAPK signaling. The transcription factor KFL4 was shared among the 3 types of dementia. Conclusions: Collectively, we identified similarities and differences in dysregulated pathways and transcription factors among the dementias. The shared pathways and transcription factors may indicate a potential common etiology, whereas the differences may be useful for distinguishing dementias. Full article
(This article belongs to the Special Issue Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules)
►▼ Show Figures

Figure 1

21 pages, 3863 KiB  
Article
Differential Expression of miRNAs and Behavioral Change in the Cuprizone-Induced Demyelination Mouse Model
by Seung Ro Han, Yun Hee Kang, Hyungtaek Jeon, Suhyuk Lee, Sang-Jin Park, Dae-Yong Song, Sun Seek Min, Seung-Min Yoo, Myung-Shin Lee and Seung-Hoon Lee
Int. J. Mol. Sci. 2020, 21(2), 646; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21020646 - 18 Jan 2020
Cited by 18 | Viewed by 4286
Abstract
The demyelinating diseases of the central nervous system involve myelin abnormalities, oligodendrocyte damage, and consequent glia activation. Neurotoxicant cuprizone (CPZ) was used to establish a mouse model of demyelination. However, the effects of CPZ on microRNA (miRNA) expression and behavior have not been [...] Read more.
The demyelinating diseases of the central nervous system involve myelin abnormalities, oligodendrocyte damage, and consequent glia activation. Neurotoxicant cuprizone (CPZ) was used to establish a mouse model of demyelination. However, the effects of CPZ on microRNA (miRNA) expression and behavior have not been clearly reported. We analyzed the behavior of mice administered a diet containing 0.2% CPZ for 6 weeks, followed by 6 weeks of recovery. Rotarod analysis demonstrated that the treated group had poorer motor coordination than control animals. This effect was reversed after 6 weeks of CPZ withdrawal. Open-field tests showed that CPZ-treated mice exhibited significantly increased anxiety and decreased exploratory behavior. CPZ-induced demyelination was observed to be alleviated after 4 weeks of CPZ treatment, according to luxol fast blue (LFB) staining and myelin basic protein (MBP) expression. miRNA expression profiling showed that the expression of 240 miRNAs was significantly changed in CPZ-fed mice compared with controls. Furthermore, miR-155-5p and miR-20a-5p upregulations enhanced NgR induction through Smad 2 and Smad 4 suppression in demyelination. Taken together, our results demonstrate that CPZ-mediated demyelination induces behavioral deficits with apparent alterations in miRNA expression, suggesting that differences in miRNA expression in vivo may be new potential therapeutic targets for remyelination. Full article
(This article belongs to the Special Issue Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules)
►▼ Show Figures

Figure 1

9 pages, 1074 KiB  
Article
Docosahexaenoic Acid Attenuates Mitochondrial Alterations and Oxidative Stress Leading to Cell Death Induced by Very Long-Chain Fatty Acids in a Mouse Oligodendrocyte Model
by Thomas Nury, Margaux Doria, Gérard Lizard and Anne Vejux
Int. J. Mol. Sci. 2020, 21(2), 641; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21020641 - 18 Jan 2020
Cited by 10 | Viewed by 2868
Abstract
In the case of neurodegenerative pathologies, the therapeutic arsenal available is often directed towards the consequences of the disease. The purpose of this study is, therefore, to evaluate the ability of docosahexaenoic acid (DHA), a molecule present in certain foods and considered to [...] Read more.
In the case of neurodegenerative pathologies, the therapeutic arsenal available is often directed towards the consequences of the disease. The purpose of this study is, therefore, to evaluate the ability of docosahexaenoic acid (DHA), a molecule present in certain foods and considered to have health benefits, to inhibit the cytotoxic effects of very long-chain fatty acids (C24:0, C26:0), which can contribute to the development of some neurodegenerative diseases. The effect of DHA (50 µM) on very long-chain fatty acid-induced toxicity was studied by several complementary methods: phase contrast microscopy to evaluate cell viability and morphology, the MTT test to monitor the impact on mitochondrial function, propidium iodide staining to study plasma membrane integrity, and DHE staining to measure oxidative stress. A Western blot assay was used to assess autophagy through modification of LC3 protein. The various experiments were carried out on the cellular model of 158N murine oligodendrocytes. In 158N cells, our data establish that DHA is able to inhibit all tested cytotoxic effects induced by very long-chain fatty acids. Full article
(This article belongs to the Special Issue Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules)
►▼ Show Figures

Figure 1

13 pages, 3618 KiB  
Article
Mechanisms of Neuronal Death in the Cerebral Cortex during Aging and Development of Alzheimer’s Disease-Like Pathology in Rats
by Darya V. Telegina, Gleb K. Suvorov, Oyuna S. Kozhevnikova and Nataliya G. Kolosova
Int. J. Mol. Sci. 2019, 20(22), 5632; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20225632 - 11 Nov 2019
Cited by 30 | Viewed by 3746
Abstract
Alzheimer’s disease (AD) is the commonest type of late-life dementia and damages the cerebral cortex, a vulnerable brain region implicated in memory, emotion, cognition, and decision-making behavior. AD is characterized by progressive neuronal loss, but the mechanisms of cell death at different stages [...] Read more.
Alzheimer’s disease (AD) is the commonest type of late-life dementia and damages the cerebral cortex, a vulnerable brain region implicated in memory, emotion, cognition, and decision-making behavior. AD is characterized by progressive neuronal loss, but the mechanisms of cell death at different stages of the disease remain unknown. Here, by means of OXYS rats as an appropriate model of the most common (sporadic) AD form, we studied the main pathways of cell death during development of AD-like pathology, including the preclinical stage. We found that apoptosis is activated at the pre-symptomatic stage (age 20 days) correlating with the retardation of brain development in the OXYS strain early in life. Progression of the AD-like pathology was accompanied by activation of apoptosis and necroptosis resulting from a decline of autophagy-mediated proteostasis. Our results are consistent with the idea that the nature of changes in the pathways of apoptosis, autophagy, and necrosis depends on the stage of AD. Full article
(This article belongs to the Special Issue Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules)
►▼ Show Figures

Figure 1

13 pages, 2395 KiB  
Article
Nimodipine-Dependent Protection of Schwann Cells, Astrocytes and Neuronal Cells from Osmotic, Oxidative and Heat Stress Is Associated with the Activation of AKT and CREB
by Sandra Leisz, Sebastian Simmermacher, Julian Prell, Christian Strauss and Christian Scheller
Int. J. Mol. Sci. 2019, 20(18), 4578; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms20184578 - 16 Sep 2019
Cited by 21 | Viewed by 3670
Abstract
Clinical and experimental data assumed a neuroprotective effect of the calcium channel blocker nimodipine. However, it has not been proven which neuronal or glial cell types are affected by nimodipine and which mechanisms underlie these neuroprotective effects. Therefore, the aim of this study [...] Read more.
Clinical and experimental data assumed a neuroprotective effect of the calcium channel blocker nimodipine. However, it has not been proven which neuronal or glial cell types are affected by nimodipine and which mechanisms underlie these neuroprotective effects. Therefore, the aim of this study was to investigate the influence of nimodipine treatment on the in vitro neurotoxicity of different cell types in various stress models and to identify the associated molecular mechanisms. Therefore, cell lines from Schwann cells, neuronal cells and astrocytes were pretreated for 24 h with nimodipine and incubated under stress conditions such as osmotic, oxidative and heat stress. The cytotoxicity was measured via the lactate dehydrogenase (LDH) activity of cell culture supernatant. As a result, the nimodipine treatment led to a statistically significantly reduced cytotoxicity in Schwann cells and neurons during osmotic (p ≤ 0.01), oxidative (p ≤ 0.001) and heat stress (p ≤ 0.05), when compared to the vehicle. The cytotoxicity of astrocytes was nimodipine-dependently reduced during osmotic (p ≤ 0.01), oxidative (p ≤ 0.001) and heat stress (not significant). Moreover, a decreased caspase activity as well as an increased proteinkinase B (AKT) and cyclic adenosine monophosphate response element-binding protein (CREB) phosphorylation could be observed after the nimodipine treatment under different stress conditions. These results demonstrate a cell type-independent neuroprotective effect of the prophylactic nimodipine treatment, which is associated with the prevention of stress-dependent apoptosis through the activation of CREB and AKT signaling pathways and the reduction of caspase 3 activity. Full article
(This article belongs to the Special Issue Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules)
►▼ Show Figures

Figure 1

Review

Jump to: Editorial, Research

17 pages, 675 KiB  
Review
Metal Imbalance in Neurodegenerative Diseases with a Specific Concern to the Brain of Multiple Sclerosis Patients
by Jean-Philippe Dales and Sophie Desplat-Jégo
Int. J. Mol. Sci. 2020, 21(23), 9105; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21239105 - 30 Nov 2020
Cited by 18 | Viewed by 3296
Abstract
There is increasing evidence that deregulation of metals contributes to a vast range of neurodegenerative diseases including multiple sclerosis (MS). MS is a chronic inflammatory disease of the central nervous system (CNS) manifesting disability and neurological symptoms. The precise origin of MS is [...] Read more.
There is increasing evidence that deregulation of metals contributes to a vast range of neurodegenerative diseases including multiple sclerosis (MS). MS is a chronic inflammatory disease of the central nervous system (CNS) manifesting disability and neurological symptoms. The precise origin of MS is unknown, but the disease is characterized by focal inflammatory lesions in the CNS associated with an autoimmune reaction against myelin. The treatment of this disease has mainly been based on the prescription of immunosuppressive and immune-modulating agents. However, the rate of progressive disability and early mortality is still worrisome. Metals may represent new diagnostic and predictive markers of severity and disability as well as innovative candidate drug targets for future therapies. In this review, we describe the recent advances in our understanding on the role of metals in brain disorders of neurodegenerative diseases and MS patients. Full article
(This article belongs to the Special Issue Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules)
►▼ Show Figures

Graphical abstract

30 pages, 5732 KiB  
Review
Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases
by Fang Luo, Aaron F. Sandhu, Wiramon Rungratanawanich, George E. Williams, Mohammed Akbar, Shuanhu Zhou, Byoung-Joon Song and Xin Wang
Int. J. Mol. Sci. 2020, 21(19), 7174; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21197174 - 28 Sep 2020
Cited by 88 | Viewed by 11122
Abstract
With aging, the nervous system gradually undergoes degeneration. Increased oxidative stress, endoplasmic reticulum stress, mitochondrial dysfunction, and cell death are considered to be common pathophysiological mechanisms of various neurodegenerative diseases (NDDs) such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), organophosphate-induced [...] Read more.
With aging, the nervous system gradually undergoes degeneration. Increased oxidative stress, endoplasmic reticulum stress, mitochondrial dysfunction, and cell death are considered to be common pathophysiological mechanisms of various neurodegenerative diseases (NDDs) such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), organophosphate-induced delayed neuropathy (OPIDN), and amyotrophic lateral sclerosis (ALS). Autophagy is a cellular basic metabolic process that degrades the aggregated or misfolded proteins and abnormal organelles in cells. The abnormal regulation of neuronal autophagy is accompanied by the accumulation and deposition of irregular proteins, leading to changes in neuron homeostasis and neurodegeneration. Autophagy exhibits both a protective mechanism and a damage pathway related to programmed cell death. Because of its “double-edged sword”, autophagy plays an important role in neurological damage and NDDs including AD, PD, HD, OPIDN, and ALS. Melatonin is a neuroendocrine hormone mainly synthesized in the pineal gland and exhibits a wide range of biological functions, such as sleep control, regulating circadian rhythm, immune enhancement, metabolism regulation, antioxidant, anti-aging, and anti-tumor effects. It can prevent cell death, reduce inflammation, block calcium channels, etc. In this review, we briefly discuss the neuroprotective role of melatonin against various NDDs via regulating autophagy, which could be a new field for future translational research and clinical studies to discover preventive or therapeutic agents for many NDDs. Full article
(This article belongs to the Special Issue Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules)
►▼ Show Figures

Figure 1

16 pages, 827 KiB  
Review
Participation of Amyloid and Tau Protein in Neuronal Death and Neurodegeneration after Brain Ischemia
by Ryszard Pluta, Marzena Ułamek-Kozioł, Sławomir Januszewski and Stanisław J. Czuczwar
Int. J. Mol. Sci. 2020, 21(13), 4599; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21134599 - 28 Jun 2020
Cited by 20 | Viewed by 2330
Abstract
Current evidence indicates that postischemic brain injury is associated with the accumulation of folding proteins, such as amyloid and tau protein, in the intra- and extracellular spaces of neuronal cells. In this review, we summarize protein changes associated with Alzheimer’s disease and their [...] Read more.
Current evidence indicates that postischemic brain injury is associated with the accumulation of folding proteins, such as amyloid and tau protein, in the intra- and extracellular spaces of neuronal cells. In this review, we summarize protein changes associated with Alzheimer’s disease and their gene expression (amyloid protein precursor and tau protein) after brain ischemia, and their roles in the postischemic period. Recent advances in understanding the postischemic mechanisms in development of neurodegeneration have revealed dysregulation of amyloid protein precursor, α-, β- and γ-secretase and tau protein genes. Reduced expression of the α-secretase gene after brain ischemia with recirculation causes neuronal cells to be less resistant to injury. We present the latest data that Alzheimer’s disease-related proteins and their genes play a crucial role in postischemic neurodegeneration. Understanding the underlying processes of linking Alzheimer’s disease-related proteins and their genes in development of postischemic neurodegeneration will provide the most significant goals to date for therapeutic development. Full article
(This article belongs to the Special Issue Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules)
►▼ Show Figures

Figure 1

17 pages, 1167 KiB  
Review
The Potential for Natural Antioxidant Supplementation in the Early Stages of Neurodegenerative Disorders
by Francesca Oppedisano, Jessica Maiuolo, Micaela Gliozzi, Vincenzo Musolino, Cristina Carresi, Saverio Nucera, Miriam Scicchitano, Federica Scarano, Francesca Bosco, Roberta Macrì, Stefano Ruga, Maria Caterina Zito, Ernesto Palma, Carolina Muscoli and Vincenzo Mollace
Int. J. Mol. Sci. 2020, 21(7), 2618; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21072618 - 09 Apr 2020
Cited by 36 | Viewed by 3885
Abstract
The neurodegenerative process is characterized by the progressive ultrastructural alterations of selected classes of neurons accompanied by imbalanced cellular homeostasis, a process which culminates, in the later stages, in cell death and the loss of specific neurological functions. Apart from the neuronal cell [...] Read more.
The neurodegenerative process is characterized by the progressive ultrastructural alterations of selected classes of neurons accompanied by imbalanced cellular homeostasis, a process which culminates, in the later stages, in cell death and the loss of specific neurological functions. Apart from the neuronal cell impairment in selected areas of the central nervous system which characterizes many neurodegenerative diseases (e.g., Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, etc.), some alterations may be found in the early stages including gliosis and the misfolding or unfolding accumulation of proteins. On the other hand, several common pathophysiological mechanisms can be found early in the course of the disease including altered oxidative metabolism, the loss of cross-talk among the cellular organelles and increased neuroinflammation. Thus, antioxidant compounds have been suggested, in recent years, as a potential strategy for preventing or counteracting neuronal cell death and nutraceutical supplementation has been studied in approaching the early phases of neurodegenerative diseases. The present review will deal with the pathophysiological mechanisms underlying the early stages of the neurodegenerative process. In addition, the potential of nutraceutical supplementation in counteracting these diseases will be assessed. Full article
(This article belongs to the Special Issue Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules)
►▼ Show Figures

Figure 1

19 pages, 1303 KiB  
Review
Lipids Nutrients in Parkinson and Alzheimer’s Diseases: Cell Death and Cytoprotection
by Thomas Nury, Gérard Lizard and Anne Vejux
Int. J. Mol. Sci. 2020, 21(7), 2501; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21072501 - 03 Apr 2020
Cited by 13 | Viewed by 4752
Abstract
Neurodegenerative diseases, particularly Parkinson’s and Alzheimer’s, have common features: protein accumulation, cell death with mitochondrial involvement and oxidative stress. Patients are treated to cure the symptoms, but the treatments do not target the causes; so, the disease is not stopped. It is interesting [...] Read more.
Neurodegenerative diseases, particularly Parkinson’s and Alzheimer’s, have common features: protein accumulation, cell death with mitochondrial involvement and oxidative stress. Patients are treated to cure the symptoms, but the treatments do not target the causes; so, the disease is not stopped. It is interesting to look at the side of nutrition which could help prevent the first signs of the disease or slow its progression in addition to existing therapeutic strategies. Lipids, whether in the form of vegetable or animal oils or in the form of fatty acids, could be incorporated into diets with the aim of preventing neurodegenerative diseases. These different lipids can inhibit the cytotoxicity induced during the pathology, whether at the level of mitochondria, oxidative stress or apoptosis and inflammation. The conclusions of the various studies cited are oriented towards the preventive use of oils or fatty acids. The future of these lipids that can be used in therapy/prevention will undoubtedly involve a better delivery to the body and to the brain by utilizing lipid encapsulation. Full article
(This article belongs to the Special Issue Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules)
►▼ Show Figures

Figure 1

21 pages, 706 KiB  
Review
Role of Alcohol Drinking in Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis
by Bin Peng, Qiang Yang, Rachna B Joshi, Yuancai Liu, Mohammed Akbar, Byoung-Joon Song, Shuanhu Zhou and Xin Wang
Int. J. Mol. Sci. 2020, 21(7), 2316; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21072316 - 27 Mar 2020
Cited by 70 | Viewed by 16039
Abstract
Neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS), increase as the population ages around the world. Environmental factors also play an important role in most cases. Alcohol consumption exists extensively and it acts as one of the [...] Read more.
Neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS), increase as the population ages around the world. Environmental factors also play an important role in most cases. Alcohol consumption exists extensively and it acts as one of the environmental factors that promotes these neurodegenerative diseases. The brain is a major target for the actions of alcohol, and heavy alcohol consumption has long been associated with brain damage. Chronic alcohol intake leads to elevated glutamate-induced excitotoxicity, oxidative stress and permanent neuronal damage associated with malnutrition. The relationship and contributing mechanisms of alcohol with these three diseases are different. Epidemiological studies have reported a reduction in the prevalence of Alzheimer’s disease in individuals who drink low amounts of alcohol; low or moderate concentrations of ethanol protect against β-amyloid (Aβ) toxicity in hippocampal neurons; and excessive amounts of ethanol increase accumulation of Aβ and Tau phosphorylation. Alcohol has been suggested to be either protective of, or not associated with, PD. However, experimental animal studies indicate that chronic heavy alcohol consumption may have dopamine neurotoxic effects through the induction of Cytochrome P450 2E1 (CYP2E1) and an increase in the amount of α-Synuclein (αSYN) relevant to PD. The findings on the association between alcohol consumption and ALS are inconsistent; a recent population-based study suggests that alcohol drinking seems to not influence the risk of developing ALS. Additional research is needed to clarify the potential etiological involvement of alcohol intake in causing or resulting in major neurodegenerative diseases, which will eventually lead to potential therapeutics against these alcoholic neurodegenerative diseases. Full article
(This article belongs to the Special Issue Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-14
Back to TopTop